Already positive, the research from Deutsche Bank and its analyst Alfredo Alonso still consider the stock as a Buy opportunity. The target price remains set at EUR 8.40. | March 31, 2023
Advances in Genome Biology and Technology delivers cutting-edge genomics news by day, holds beachside festivities (enlivened by Flo Rida’s “Low”) at night.